Olivier Visa Net Worth

Olivier Visa biography

Olivier M. Visa is Vice President - OEM, Sports and Donor Services of the Company. He was named Vice President, OEM and sports in September 2017. Mr. Visa has 25 years of commercial leadership experience in the global healthcare industry with a focus on transforming businesses and building sustainable value. Mr. Visa’s experience in the life sciences industry includes medical devices, pharmaceuticals and biologics across multiple countries in the pharmacy and critical care markets. Prior to joining RTI in October 2017, Mr. Visa served as vice president for the Global Compounding business unit of Baxter Healthcare from July 2013 to September 2017. In this role, Mr. Visa oversaw the global profitability improvement of the outsourcing pharmacy business while focusing operations, quality and research and development efforts on patient safety and innovation. Prior to this role, Mr. Visa had multiple commercial responsibilities in the Baxter Pharmaceuticals and Technology franchise from November 2004 to June 2013. In addition, Mr. Visa previously served the Global Drug Delivery business through mergers, acquisitions, licensing and integrations in multiple geographies and led marketing for the contract manufacturing business from August 2001 to October 2004. Mr. Visa earned a doctorate degree in pharmacy from the University of Aix Marseille II and a Master of Business Administration from the Kellogg School of Management.

What is the salary of Olivier Visa?

As the Vice President - OEM és Sports and Donor Services of RTI Surgical, the total compensation of Olivier Visa at RTI Surgical is $655,466. There are 2 executives at RTI Surgical getting paid more, with Jonathon Singer having the highest compensation of $2,188,310.

How old is Olivier Visa?

Olivier Visa is 50, he's been the Vice President - OEM és Sports and Donor Services of RTI Surgical since 2017. There are 8 older and 2 younger executives at RTI Surgical. The oldest executive at RTI Surgical Holdings, Inc. is Thomas McEachin, 67, who is the Independent Director.

What's Olivier Visa's mailing address?

Olivier's mailing address filed with the SEC is 520 LAKE COOK ROAD, SUITE 315, , DEERFIELD, IL, 60015.

Insiders trading at RTI Surgical

Over the last 21 years, insiders at RTI Surgical have traded over $71,830 worth of RTI Surgical stock and bought 390,515 units worth $1,973,594 . The most active insiders traders include Jeffrey C Lightcap, Mark Stolper és Terry M. Rich. On average, RTI Surgical executives and independent directors trade stock every 138 days with the average trade being worth of $62,561. The most recent stock trade was executed by Jonathon M Singer on 12 December 2018, trading 50,000 units of RTIX stock currently worth $214,000.

What does RTI Surgical do?

RTI Surgical Holdings, Inc. engages in the provision of biologic, metal, and synthetic-based surgical implants. It offers implants in the following categories: extremities, orthobiologics, spine, sports medicine, and surgical specialties. The company was founded in February 1998 and is headquartered in Deerfield, IL.

RTI Surgical executives and stock owners

RTI Surgical executives and other stock owners filed with the SEC include:

• Jonathon Singer,
  Chief Financial Officer, Chief Operating Officer
• John Varela,
  Executive Vice President - Global Operations
• Olivier Visa,
  Vice President - OEM, Sports and Donor Services
• Shirley Weis,
  Independent Director
• Thomas McEachin,
  Independent Director
• Mark Stolper,
  Lead Independent Director
• Paul Thomas,
  Independent Director
• Nicholas Valeriani,
  Independent Director
• Pawel Lewicki,
  Director
• Scott Durall,
  Chief Commercial Officer
• Bryan Cornwall,
  Executive Vice President - Research and Clinical Affairs
• Stuart Simpson,
  Chairman of the Board
• Molly Poarch,
  Director, Corporate Communications & Investor Relations
• Jeffrey Lightcap,
  Independent Director
• Brian Kushner,
  Director
• Ryan Bartolucci,
  Vice President - Finance, Corporate Controller
• Terry Rich,
  President, Chief Executive Officer, Director
• Lyle P. Luedeman,
  
• Dean H Bergy,
  Director
• Street Healthcare Partners ...,
  
• Christopher R Sweeney,
  Director
• Curtis M Selquist,
  Director
• Peter F Gearen,
  Director
• Brian K Hutchison,
  Chairman, President and CEO
• Camille Farhat,
  Chief Executive Officer
• Robert P Jordheim,
  Executive Vice President/CFO
• Roger W Rose,
  Vice President Donor Services
• Johannes Wynand Louw,
  Vice President Finance
• Kevin D Brandt,
  EVP CCO-Domestic Direct
• Joshua H De Rienzis,
  General Counsel
• Philip R Chapman,
  Director
• Ned Hoye Villers,
  Director
• Adrian J R Smith,
  Director
• Caroline A Hartill,
  V.P. Quality Assurance
• Julianne M Bowler,
  Director
• Roy D Crowninshield,
  Director
• Gregory P Rainey,
  Director
• Neal B Freeman,
  Director
• Michael J La Prade,
  Vice President
• Holdings Inc Zimmer,
  10% owner
• Roderick N Allen,
  Vice President
• David J Simpson,
  Director
• Guy L Mayer,
  President
• Michael J Odrich,
  Director
• Lee Robert Jr Johnston,
  Vice President
• Udo Henseler,
  Director
• Christie J Blakely,
  Vice President
• Robert J Lane,
  Vice President
• Tara Leigh Zerby,
  VP, Xenograft Technologies
• Carolyn Shaffer,
  Vice President, Human Resource
• Thomas F Rose,
  Vice President and CFO
• Michael T Manley,
  Director
• Louis E Barnes,
  Vice President-Cardiovascular
• Charles Randal Mills,
  V.P. of Business Development
• William Melendez,
  Vice President, Research & Dev
• Jeffrey Michael Schumm,
  Vice Pres. and General Counsel
• Joseph W Condon,
  Vice President-Operations